{"id":"apl-9796","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, I do not have enough information to provide a deeper explanation of the mechanism.","oneSentence":"APL-9796 is a small molecule that targets the [insert target here, if known].","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:28:47.823Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 2 for [insert indication here, if known]"}]},"trialDetails":[{"nctId":"NCT06846554","phase":"PHASE2","title":"A Trial of \"APL-9796'' in Adults With Pulmonary Hypertension","status":"RECRUITING","sponsor":"Apollo Therapeutics Ltd","startDate":"2025-04-09","conditions":"Pulmonary Arterial Hypertension","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"APL-9796","genericName":"APL-9796","companyName":"Apollo Therapeutics Ltd","companyId":"apollo-therapeutics-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"APL-9796 is a small molecule that targets the [insert target here, if known]. Used for Phase 2 for [insert indication here, if known].","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}